Drug price display initiative continues in Malaysia from Aug 1
The phased implementation, which began on August 1, follows an initial educational enforcement period from May 1 to July 31.
A joint statement from both ministries confirmed that 842 facilities, including medical clinics, dental clinics, private hospitals, and community pharmacies, were inspected during the initial phase.
Of these, 57 per cent complied with the drug price display requirements.
'Enforcement will continue through inspections and advocacy until September 30, with reminder letters issued for non-compliance,' the statement said.
Full enforcement, including penalties for repeat offences, will begin on January 1, 2026.
The ministries acknowledged a judicial review filed by seven medical and dental organisations challenging the validity of the Price Control and Anti-Profiteering (Price Marking of Medicines) Order 2025.
However, they clarified that no court order has suspended the initiative, meaning the regulation remains in effect.
MOH and KPDN reiterated their commitment to implementing the policy in a structured manner to enhance transparency and consumer trust in Malaysia's healthcare system. - Bernama
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
3 hours ago
- Malay Mail
Not enough doctors, nurses: Pasir Gudang Hospital launch pushed to next year
JOHOR BAHRU, Aug 4 — The opening of the Pasir Gudang Hospital (HPG) here, which was initially scheduled to begin phased operations on Aug 1, has been postponed to next year. Johor Health and Environment Committee chairman Ling Tian Soon said this was due to several technical issues, including a shortage of healthcare personnel, such as doctors and nurses. According to him, the decision was agreed upon by both the Ministry of Health and the state government to avoid any complications arising from inadequate staffing. 'The shortage of healthcare staff is one of the major issues we are currently facing. If the hospital were to begin operations without sufficient manpower, we are concerned it would lead to various problems in the future. 'However, HPG will not be left idle. Instead, it will serve as a support facility for Sultanah Aminah Hospital (HSA) and Sultan Ismail Hospital (HSI), which are the two busiest hospitals in the state,' he said when contacted today. He added that discussions with the Ministry of Health (MOH) will continue to ensure HPG can begin operating with an adequate number of staff. In June, Health Minister Datuk Seri Dr Dzulkefly Ahmad was reported as saying that HPG would begin its first phase of operations on Aug 1, involving around 30 per cent of its total hospital capacity. He said the initial phase would cover 30 per cent of essential services such as Accident and Emergency (A&E), Obstetrics and Gynaecology, and the Paediatrics Department. 'To date, 274 positions have been filled, and we hope the hospital can become fully operational with 1,845 staff by July 2026,' he said. — Bernama
The Star
15 hours ago
- The Star
Medicine price display rule to stay
PETALING JAYA: The enforcement of the medicine price display requirement under the Price Control and Anti-Profiteering Act 2011 will continue in stages through a process of education, inspections, and advocacy until Sept 30. The Health Ministry said in a statement that warning letters may be issued for non-compliance, followed by the issuance of compounds from Oct 1. Full enforcement is scheduled to begin on Jan 1 next year. The medicine price display initiative, which applies to private healthcare facilities and community pharmacies, was first implemented on May 1. 'This initiative is a strategic collaboration between the Health Ministry and the Domestic Trade and Cost of Living Ministry. 'An educational enforcement approach was adopted for the first three months, ending July 31. 'During this period, 842 facilities, including medical and dental clinics, private hospitals, and community pharmacies, were inspected, with 57% found to be satisfactorily complying with the price display requirement,' the ministry said yesterday. Both ministries also acknowledged that a judicial review had been filed in the High Court by seven organisations representing medical and dental practitioners, as well as one private medical practitioner, to challenge the validity of the directive. However, the ministry clarified that no court order has been issued to suspend the implementation or enforcement of the ruling. Former Medical Practitioners Coalition Association of Malaysia president Dr Raj Kumar Maharajah said most clinics are not in favour of the rule but have complied regardless. He argued that the directive is misplaced, as private clinics do not operate like pharmacies and do not display or sell medicines over the counter. 'Unlike pharmacies that sell medicines, our permits allow us to dispense medication only after consultation, examination and investigations. 'Customers rarely come just to buy medicine and the drugs are not displayed on shelves. 'When we introduce laws, they must make sense. 'This rule seems more like a feel-good measure to reassure the public. But in reality, it serves no purpose,' he said. On the question of compliance, Dr Raj said clinics are ready for full enforcement and have nothing to hide. Federation of Private Medical Practitioners' Associations Malaysia secretary Dr Shanmuganathan Ganeson said the association understands the enforcement is still in its educational phase until the end of September and that compounds are unlikely during this period. He said members have been advised to cooperate during inspections and continue engaging in good faith. 'We've filed a judicial review, so we'll refrain from making detailed comments while the matter is before the court. 'If any clinic experiences overzealous or premature enforcement, we encourage them to inform the federation's secretariat so we can monitor and respond accordingly,' he said. The directive, effective from May 1, requires all private healthcare facilities and community pharmacies to display prices of all medicines intended for human use. This includes prescription and non-prescription drugs, over the counter products, traditional medicines, health supplements, and extemporaneously prepared products.
Malay Mail
a day ago
- Malay Mail
Drug price transparency kicks in at private clinics and pharmacies, full enforcement by January 2026
KUALA LUMPUR, Aug 3 — The Ministry of Health (MOH) and the Ministry of Domestic Trade and Cost of Living (KPDN) are implementing the drug price display initiative at private health facilities and community pharmacies in stages starting August 1. According to a joint statement by both ministries, the initiative, which was implemented under the Price Control and Anti-Profiteering (Price Marking of Medicines) Order 2025 [P.U.(A) 141/2025] under the Price Control and Anti-Profiteering Act 2011, began on May 1. The statement said the educational enforcement approach was implemented in the first three months ending July 31. 'During the period, 842 facilities consisting of medical clinics, dental clinics and private hospitals as well as community pharmacies were inspected and the majority of them have implemented this initiative with 57 per cent of them complying with the requirements for satisfactory drug price display,' according to the statement. In this regard, enforcement will continue in stages from August 1 through educational approach inspections and advocacy for two months until September 30 and a reminder letter may be issued in the event of non-compliance. According to the statement, starting October 1, compounds would be issued for repeat offences before full enforcement on January 1, 2026. MOH and KPDN also took note of the judicial review action filed in the High Court by seven organisations representing medical and dental practitioners and one private medical practitioner regarding the validity of Order PU (A) 141/2025. 'However, until this statement is issued, there is no court order directing the suspension of the implementation or enforcement of this order. Therefore, Order P.U.(A) 141/2025 remains valid and in force,' according to the statement. MOH and KPDN also expressed their commitment to implement the initiative in an inclusive, phased and prudent manner to ensure that its benefits are enjoyed by consumers and contribute to increasing transparency, accountability and trust in the country's health system. — Bernama
